Albuterol

Excerpt

Albuterol, also known as salbutamol, is approved by the U.S. Food and Drug Association (FDA) for treating and preventing acute or severe bronchospasm in patients with reversible obstructive airway disease, including exercise-induced bronchospasm. Albuterol is a commonly prescribed bronchodilator used for managing diverse respiratory conditions, including asthma and exercise-induced bronchospasm. This activity covers the appropriate indications, administration, contraindications, adverse drug reactions, and precautions associated with albuterol to ensure its safe and proper utilization. This activity also aims to equip healthcare professionals with a comprehensive understanding of albuterol therapy in obstructive airway diseases, allowing for efficient and effective drug use in clinical settings.